Cargando…

Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491

Detalles Bibliográficos
Autores principales:	Bellows, Steven, Jankovic, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076880/ https://www.ncbi.nlm.nih.gov/pubmed/31979241 http://dx.doi.org/10.3390/toxins12020072

Ejemplares similares

Comments on Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491
por: Foster, Keith, et al.
Publicado: (2020)

Immunogenicity Associated with Botulinum Toxin Treatment
por: Bellows, Steven, et al.
Publicado: (2019)

Reply to Comment on Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures. Toxins 2018, 10, 18—Quintessential Use of Ultrasound Guidance for Botulinum Toxin Injections
por: Alter, Katharine E., et al.
Publicado: (2018)

Reply to Comments on “Shiga-Toxin Producing Escherichia coli in Brazil: A Systematic Review. Microorganisms 2019, 7, 137”
por: Castro, Vinicius Silva, et al.
Publicado: (2019)

Reply to the Comment Re: Magalhães-Sant’Ana, M. Animals 2019, 9, 168
por: Magalhães-Sant’Ana, Manuel
Publicado: (2020)

Reply to Comment on Detection of Mycotoxin in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605-617 by Mark J. Mendell †
por: Brewer, Joseph, et al.
Publicado: (2016)

Reply to “Comments on the Editor Re: The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097.”
por: Vidot, Helen, et al.
Publicado: (2020)

Reply to Comment on Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome Toxins 2013, 5, 605–617 by John W. Osterman, M.D. †
por: Brewer, Joseph, et al.
Publicado: (2016)

Reply: “Letter to the Editor Re: Oh J., et al. Nutrients 2019, 11, 343”
por: Oh, Jongwon, et al.
Publicado: (2019)

Reply to “Letter to the Editor Re: Scott S.N., et al. Nutrients 2019, 11(5), 1022”
por: Scott, Sam N., et al.
Publicado: (2019)

Reply to Comments on the editor Re: Carsten Posovszky et al. “Roles of Lactose and Fructose Malabsorption and Dietary Outcomes in Children Presenting with Chronic Abdominal Pain.”, Nutrients 2019, 11(12), 3063
por: Posovszky, Carsten, et al.
Publicado: (2020)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Reply: “Comment on Search and Selection of Probiotics that Improve Mucositis Symptoms in Oncologic Patients. A Systematic Review. Nutrients 2019, 11, 2322”
por: Picó-Monllor, José Antonio, et al.
Publicado: (2020)

Reply to Comments on Proteomic Investigations of Two Pakistani Naja Snake Venom Species Unravel the Venom Complexity, Posttranslational Modifications, and Presence of Extracellular Vesicles. Toxins 2020, 12, 669
por: Munawar, Aisha, et al.
Publicado: (2020)

Reply to “Comments on the Editor Re: Shi, Zumin, et al. High Chili Intake and Cognitive Function among 4582 Adults: An Open Cohort Study over 15 Years. Nutrients 11.5 (2019): 1183.”
por: Shi, Zumin, et al.
Publicado: (2019)

Reply to Comment on “Enumeration of Escherichia coli in Probiotic Products. Microorganisms 2019, 7, 437”
por: Zimmer, Camille, et al.
Publicado: (2020)

Reply to the Comment of G. Feulner
por: Weber, Werner
Publicado: (2011)

Reply to the Comment by Littlechild and Isupov
por: Willetts, Andrew, et al.
Publicado: (2017)

Reply to Comment on “Screening and Identification of Novel Ochratoxin A-Producing Fungi from Grapes”. Toxins 2016, 8, 333”–in Reporting Ochratoxin A Production from Strains of Aspergillus, Penicillium and Talaromyces
por: Zhang, Xiaoyun, et al.
Publicado: (2017)

Reply to “Utility of Unrefined Carbohydrates in Type 2 Diabetes. Comment on Reversing Type 2 Diabetes: A Narrative Review of the Evidence, Nutrients, 2019, 11, 766”
por: Hallberg, Sarah J, et al.
Publicado: (2019)

Reply to Comment on “Malfitano, A.M. et al. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer” Cancers 2019, 11, 1532
por: Malfitano, Anna Maria, et al.
Publicado: (2020)

Reply to Comment “Assessing Porous Media Permeability in Non-Darcy Flow: A Re-Evaluation Based on the Forchheimer Equation”
por: Castro, A. P. G., et al.
Publicado: (2020)

Reply to Holden and Errington, “Type II Toxin-Antitoxin Systems and Persister Cells”
por: Goormaghtigh, Frédéric, et al.
Publicado: (2018)

Reply to “Sample Size Calculation. Comment on Quantitative Ultrasound and Dual X-Ray Absorptiometry as Indicators of Bone Mineral Density in Young Women and Nutritional Factors Affecting It, Nutrients, 2019, 11, 2336”
por: Schraders, Katie, et al.
Publicado: (2019)

Reply to “When Is a Ketogenic Diet Ketogenic? Comment on Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients 2019, 11, 1156”
por: Benlloch, María, et al.
Publicado: (2019)

Clinical Relevance of Botulinum Toxin Immunogenicity
por: Benecke, Reiner
Publicado: (2012)

Botulinum Toxin for the Treatment of Hand Tremor
por: Niemann, Nicki, et al.
Publicado: (2018)

Botulinum Toxin in Movement Disorders: An Update
por: Anandan, Charenya, et al.
Publicado: (2021)

Reply to “A Gluten Reduction Is the Patients’ Choice for a Dietary ‘Bottom Up’ Approach in IBS—A Comment on “A 5Ad Dietary Protocol for Functional Bowel Disorders” Nutrients 2019, 11, 1938”
por: Ibrahim, Fandi, et al.
Publicado: (2020)

Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554
por: Macek Jilkova, Zuzana, et al.
Publicado: (2020)

Reply to “Why Secondary Analyses in Vitamin D Clinical Trials Are important and How to Improve Vitamin D Clinical Trial Outcome Analyses—A Comment on “Extra-Skeletal Effects of Vitamin D”, Nutrients 2019, 11, 1460”
por: Misra, Madhusmita, et al.
Publicado: (2019)

Reply to Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer
por: Guo, Jing, et al.
Publicado: (2019)

Reply to “Limitations of the Digestible Indispensable Amino Acid Score (DIAAS) and Choice of Statistical Reporting. Comment on “A Comparison of Dietary Protein Digestibility, Based on DIAAS Scoring, in Vegetarian and Non-Vegetarian Athletes.” Nutrients 2019, 11, 3106”
por: Johnston, Carol S., et al.
Publicado: (2020)

Reply to Comments: “Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis” Int. J. Mol. Sci., 2019, 20, 4986
por: Liu, Yu-Chin, et al.
Publicado: (2020)

Reply to: “Comment on the Role of Muscle Mass Gain Following Protein Supplementation Plus Exercise Therapy in Older Adults with Sarcopenia and Frailty Risks: A Systematic Review and Meta-Regression Analysis of Randomized Trials, Nutrients 2019, 11, 1713”
por: Liao, Chun-De, et al.
Publicado: (2019)

In Reply to: Comments on Behavior of Healthcare Workers After Injuries From Sharp Instruments
por: Adib-Hajbaghery, Mohsen, et al.
Publicado: (2014)

A Reply to “Comments on “A New Elliptical Model for Device-Free Localization””
por: Lei, Qian, et al.
Publicado: (2018)

Reply to the Comment from Watson, K.M. “Letter to the Editor Re: Kipperman, B.S. and German, A.J. Animals 2018, 8, 143” Animals 2018, 8, 179
por: Kipperman, Barry S., et al.
Publicado: (2018)

Reply to Bracke et al. Comment on “Prayag et al. Light Modulation of Human Clocks, Wake, and Sleep. Clocks&Sleep 2019, 1, 193–208”
por: Prayag, Abhishek S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b31lbsmio34duuaqc306iaou26